Literature DB >> 17718242

[Oculomotor anomalies from medications].

C Van Nechel1.   

Abstract

Many medicines, mainly with neurological purpose, interfere with the oculomotricity. The biochemistry of the oculomotor systems and thus, the mechanisms of action of these drug interferences are not completely clarified. Most medicines impair the eye movements at the level of their fine adjustment by feed-back loops implying the cerebellum. Quite often, the interferences remain asymptomatic, restricted to a saccadic pursuit, hypometric saccades or an end-point nystagmus. Sometimes however, symptoms of dizziness or oscillopsia appear, due to loss of the vestibulo-ocular reflexes efficiency. A diplopia or a blurred vision by double outline could be suggestive of an ocular motor paresis or a loss of the binocular fusion due to drugs action.

Entities:  

Mesh:

Year:  2007        PMID: 17718242

Source DB:  PubMed          Journal:  Bull Soc Belge Ophtalmol        ISSN: 0081-0746


  4 in total

1.  Summary of eye examinations of 284 patients with multiple sclerosis.

Authors:  Jan M Roodhooft
Journal:  Int J MS Care       Date:  2012

2.  Nystagmus as a discontinuation symptom after antidepressant therapy: a case report.

Authors:  Sergio L Blay
Journal:  Prim Care Companion CNS Disord       Date:  2014

Review 3.  Saccadic eye movement applications for psychiatric disorders.

Authors:  Juliana Bittencourt; Bruna Velasques; Silmar Teixeira; Luis F Basile; José Inácio Salles; Antonio Egídio Nardi; Henning Budde; Mauricio Cagy; Roberto Piedade; Pedro Ribeiro
Journal:  Neuropsychiatr Dis Treat       Date:  2013-09-16       Impact factor: 2.570

Review 4.  Eye Movement in Unipolar and Bipolar Depression: A Systematic Review of the Literature.

Authors:  Nicolas Carvalho; Eric Laurent; Nicolas Noiret; Gilles Chopard; Emmanuel Haffen; Djamila Bennabi; Pierre Vandel
Journal:  Front Psychol       Date:  2015-12-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.